missed abortion
Conditions
Interventions
Femoston group:Estradiol/estradiol to bend progesterone (estradiol 2 mg pills/estradiol 2 mg + down to 10 mg of progesterone, the Dutch abbott pharmaceutical co., LTD.), 1 tablet each time, 1 times a
Gong'anKang group:Uterine cavity with cross-linked sodium hyaluronate gel: 3.0 ml/branch, changzhou raj biological pharmaceutical co., LTD., uterine cavity with postoperative uterine cavity injection
Control group:no
Sponsors
Shanghai Putuo District Maternity and Child Center
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Menopause =12 weeks, embryo termination, need to undergo curettage, have reproductive requirements; (2) Patients with no contraindications or serious systemic diseases during preoperative routine examination; (3) Informed consent, and follow-up can be performed as required
Exclusion criteria
Exclusion criteria: (1) Allergic to sodium hyaluronate; (2) Allergic to 17-ß-estradiol and dydrogesterone active components of the product or any excipient; (3) unable to use effective contraceptive measures within 3 months after operation; (4) genital tract malformation; (5) Patients with genital tract inflammation, pelvic inflammation, malignant tumors and other systemic diseases causing abnormal uterine bleeding; (6) with a history of mental illness; (7) Abnormal ovulation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uterine adhesion rate after missed abortion curettage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Missed vaginal bleeding time after abortion curettage;Missed menstrual recovery time after abortion curettage;Changes of menstrual volume before and after missed abortion curettage;Recovery time of menstruation after curettage;After two weeks of endometrial thickness; | — |
Countries
Chian
Contacts
Public ContactSheng Huilin
Shanghai Putuo District Maternity and Child Center
Outcome results
None listed